5.670 2.72%

Research Hotspot

Click Each Keyword to Figure Out More

Molecular Therapy - Nucleic Acids - Journal Impact

The Journal Impact 2019-2020 of Molecular Therapy - Nucleic Acids is 5.670, which is just updated in 2020. Compared with historical Journal Impact data, the Factor 2019 of Molecular Therapy - Nucleic Acids grew by 2.72% . The Journal Impact Quartile of Molecular Therapy - Nucleic Acids is Q1. The Journal Impact of an academic journal is a scientometric factor that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a factor for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). Note that 2019 Journal Impact are reported in 2020; they cannot be calculated until all of the 2019 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Molecular Therapy - Nucleic Acids.

7.5 ~ 8.0


1/3


Molecular Therapy - Nucleic Acids - Journal Impact Prediction System

33% scientists expect Molecular Therapy - Nucleic Acids Journal Impact 2020 will be in the range of 7.5 ~ 8.0. Journal Impact Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future factor and performance through the wisdom of crowds. Journal Impact Prediction System displays the exact community-driven factor without secret algorithms, hidden factors, or systematic delay.

Molecular Therapy - Nucleic Acids Journal Impact Prediction System - Factor and Trend
  • Article Volume 2017 162
  • Article Volume 2016 122
  • Article Volume 2015 54
  • ISSN
  • 21622531
  • Open Access
  • Publisher
  • Cell Press
  • Country/Region
  • United States
  • History
  • Categories
  • Drug Discovery (Q1), Molecular Medicine (Q1)

Molecular Therapy - Nucleic Acids - ISSN

The ISSN of Molecular Therapy - Nucleic Acids is 21622531. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Molecular Therapy - Nucleic Acids - ISSN

Molecular Therapy - Nucleic Acids - Open Access Journal

Molecular Therapy - Nucleic Acids is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Much scientific and medical research is paid for with public funds. Open Access allows taxpayers to see the results of their investment.

Molecular Therapy - Nucleic Acids - Open Access

Molecular Therapy - Nucleic Acids - Publisher

Molecular Therapy - Nucleic Acids is published by Cell Press, which is located in the United States. The Publication History of Molecular Therapy - Nucleic Acids covers 2012-ongoing.

Molecular Therapy - Nucleic Acids - Publisher

Molecular Therapy - Nucleic Acids - Categories

Molecular Therapy - Nucleic Acids is a peer-reviewed scientific journal. The scope of Molecular Therapy - Nucleic Acids covers Drug Discovery (Q1), Molecular Medicine (Q1).

Molecular Therapy - Nucleic Acids - Categories

Molecular Therapy - Nucleic Acids - Journal Factors

It is impossible to get a true picture of impact using a single factor alone, so a basket of factors is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Factors including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Molecular Therapy - Nucleic Acids.

Molecular Therapy - Nucleic Acids - Journal Metrics

Journal Ranking